KLOW Peptide Composition BPC-157 : Body Protection Compound TB-500 : Thymosin Beta-4 Fragment GHK-Cu : Copper Peptide Complex KPV : Tripeptide Sequence of Lysine, Proline, and Valine Chemical Identifiers: BPC-157 Chemical Identifiers CAS Number: 137525-51-0 ChEMBL: ChEMBL4297358 ChemSpider: 8117571 DrugBank: DB11882 PubChem CID: 9941957 UNII: 8ED8NXK95P Molecular Formula: CHNO TB-500 Chemical Identifiers CAS Number: 885340-08-9 PubChem CID: 62707662 UNII: QHK6Z47GTG Molecular Formula: CHNO GHK-Cu Chemical Identifiers CAS Number: 89030-95-5 ChEMBL: CHEBL95185 ChemSpider: 335491 DrugBank: DB14683 PubChem CID: 378611 UNII: 6BJQ43T1l9 Molecular Formula: CHCuNO KPV Chemical Identifiers CAS Number: 67727-97-3 Molecular Formula: CHNO PubChem CID: 125672 ChEMBL: CHEMBL3235483 ChemSpider: 111779 DrugBank: DB05479 KLOW Research-Based Potential Benefits Each component of KLOW has been substantially researched for its healing properties, including rodent-based studies
The activity of e-GST has been compared with the level of e-CAT, an enzyme often considered a biosensor of oxidative stress (Figure 1c)
First, reduced glycemic control
It is acetylated and amidated to improve the peptide's stability and pharmacokinetics
(The recommended dose for hypothyroidism in the 2016 study referenced earlier was 1800 mg per day
A common goal is to make 100mcg (micrograms) equivalent to a specific marking on an insulin syringe (e.g., 10 units on a U-100 syringe).Lets consider a common example: a 5mg (5000mcg) vial of peptide
